Founder/CEO of Forest (AI network for medicine); raised $150M Series C at $3B valuation (4 months after $1B); platform covers 85% US zip codes, works with 9 of top 15 biopharma.
no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY
Forest's platform provides unprecedented visibility into drug performance nationwide (40% of patients for a new autoimmune drug flowed through them), helping biopharma accelerate clinical trials, launch, and post-market tracking across 85% of US zip codes and 9 of top 15 biopharma.